ClinicalTrials.gg
Sign In
CompletedNCT00888251Updated Sep 23, 2011

Evaluation of a Weight Management Program

An observational study in Obesity, sponsored by Société des Produits Nestlé (SPN). Completed at 4 sites in United States. Per ClinicalTrials.gov, last updated 2011-09-23.

Sponsored by Société des Produits Nestlé (SPN) (part of Nestlé S.A.) · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
153
Sex
All
01

Study summary

This retrospective chart review and data abstraction will evaluate and quantify the effectiveness of a comprehensive weight management program. The hypothesis is that the program will positively affect weight, weight-related comorbidities and medication use.

02

Conditions studied

  • Obesity

Browse trials for

Keywords

  • Obesity
  • Meal replacement
  • Obesity treatment
  • Weight management
03

In context

Obesity

6,570 studies on the registry are indexed under Obesity; 1,718 are open to participants now.

This study's enrollment of 153 is above the median of 132 across 1,338 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Société des Produits Nestlé (SPN) is the lead sponsor of 324 studies on the registry; 16 are open to participants now.

Browse Société des Produits Nestlé (SPN) studies →All Nestlé S.A. studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

OPTIFAST Program participants

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Records of the first 40 study center participants who enrolled in the OPTIFAST Program from January 1, 2006 through June 30, 2006
  • Records of subjects who completed the active weight loss phase of the program
  • Records where data is available through the transitional phase of the program

Exclusion criteria

Exclusion Criteria:

  • Concurrent use of appetite suppressants or other weight loss medications
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
153 participants (actual)

Groups and cohorts

  • Comprehensive weight management program

    Other: Comprehensive weight management program

Interventions

  • OtherComprehensive weight management program

    Full meal replacement, behaviorial modification, medical monitoring, exercise.

    Also known as: OPTIFAST Program

06

Study locations

4 sites
  • Lutheran Weight Management Center
    Fort Wayne, Indiana 46804, United States
  • Mercy Center for Weight Reduction
    Des Moines, Iowa 50309, United States
  • Sparrow Weight Management Center
    East Lansing, Michigan 48823, United States
  • Jewish Hospital Weight Management Center
    Cincinnati, Ohio 45236, United States
07

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2009, a primary completion of Jul 2009 and a completion of Jul 2009. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 24, 2009
First posted
Apr 27, 2009
Start
Mar 2009
Primary completionActual
Jul 2009
CompletionActual
Jul 2009
Last update
Sep 23, 2011
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 23, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00888251
Lead sponsor
Société des Produits Nestlé (SPN)
Responsible party
Sponsor
First posted
Apr 27, 2009
Start date
Mar 2009
Primary completion
Jul 2009
Completion
Jul 2009
Last update
Sep 23, 2011

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Obesity →

Other studies from this sponsor

Société des Produits Nestlé (SPN) →

Start the discussion